In 3-fluoro-2-methylcarboxylic acids and their derivatives a change in the priority order at carbon 2 occurs upon substitution of fluorine for the hydroxy group. In the aldol products the carboxylate amide or ester takes priority over the side-chain substituent, whilst the reverse is true in the fluorine-containing compounds (rule 2). A second change in priority order occurs upon going from the carboxylic acid to the acyl-CoA ester. This is because fluorine takes priority over oxygen and nitrogen, whilst sulfur takes priority over fluorine in the acyl-CoA ester (according to rule 2) (Scheme S1). Hence the relative orientation of ligands around carbon-2 does not change in this latter reaction but the stereochemical assignment changes due to changes in ligand priority. 
Description of the AMACR reaction and its role in metabolic pathways
AMACR catalyses an in vitro reaction in which either an R-or S-2-methylacyl-CoA ester is converted into a near 1:1 mixture of the C-2 epimers. 1 The reaction differs from that of 2-methylmalony-CoA epimerase, 4, 5 in which the product has the opposite configuration at the methyl centre to the substrate, i.e. the product is only one epimer. For convenience, the AMACR catalysed reaction is described as 'racemisation' to reflect the fact that both 2-methylacyl-CoA epimers are formed in the reaction.
In vivo metabolism of 2-methyl fatty acids (as their corresponding acyl-CoA esters) occurs with a net R-to S-conversion of the chiral centre with the methyl group (C-2). This is because the S-2-methylacyl-CoA ester is removed by β-oxidation, whilst the R-2-methylacyl-CoA ester is not a substrate for the branched-chain acyl-CoA oxidase. [6] [7] [8] [9] In the metabolism of Ibuprofen TM and related 2-APA drugs, the R-2-APA is specifically converted into the R-2-APA-CoA, [10] [11] [12] [13] [14] [15] which is acted on by AMACR. Hydrolysis of the 'racemic' (2R/S) product results in a mixture of R-and S-2-APA drug, but the R-2-APA undergoes further cycles of metabolism. Since the S-2-APA is not recycled in this way, a net R-to S-conversion occurs. This three enzyme metabolic pathway is generally referred to in the literature (reviewed in 16 ) as 'chiral inversion'.
Synthesis of anti-3-fluoro-2-methyldecanoyl-CoA (2R)
anti-3-Fluoro-2-methyldecanoyl-CoA 2R was synthesised by modification of the route to anti-3-fluoro-2-methyldecanoic acid reported by Carnell et al., 17 using octanal in place of tetradecanal.
Conversion of the acid to 2R was achieved using carbonyldiimidazole as previously reported. 
(R)-4-Benzyl-3-propanoyloxazolidin-2-one (11)
N O O O R-Evans' auxiliary 10 (4.056 g, 23 mmol) in anhydrous THF (60 mL) was cooled to -78C, then nBuLi (1.6 M, 14.3 mL, 23 mmol) in THF was added dropwise and the resulting mixture was stirred at -78C for 30 min. A solution of propanoyl chloride (2.0 mL, 23 mmol) in anhydrous THF (20 mL) was added dropwise and the reaction mixture was stirred at -78C for 30 min and then allowed to reach ambient temperature over a period of 1 h. The reaction mixture was quenched by slow addition of saturated aqueous NH 4 Cl (80 mL) and extracted with DCM (2 × 100 mL). The combined organic extracts were washed with saturated aq. NaHCO 3 
(R)-4-Benzyl-3-[(2R,3S)-3-hydroxy-2-methyldecanoyl]oxazolidin-2-one (12)
Dibutylboron triflate in DCM (1.00 M, 1.30 mL, 1.29 mmol) and diisopropylethylamine (0.25 mL, 1.29 mmol) were added to a stirred solution of oxazolidinone 11 (300 mg, 2.14 mmol) in DCM (10 mL) cooled to -78C and the solution was stirred for 30 min. Octanal (0.15 mL, 0.92 mmol) in DCM (3.0 mL) was added dropwise and the reaction mixture was stirred at -78C for 30 min, then allowed to reach ambient temperature. The reaction was quenched by slow addition of phosphate buffer (0.1 M, pH = 7, 10 mL). The organic layer was then washed with aq. hydrochloric acid (1 M), saturated aq. NaHCO 3 The solution was acidified to pH ~3 with aq. HCl (1 M) and the solvents were partly removed under reduced pressure. Water (2.0 mL) was added and the mixture was washed with EtOAc (5 × 3 mL).
Solid-phase extraction of the aqueous layer gave 2R (6.0 mg) as white powder: 1 23 (12H, m), 1.21 (3H, d , J = 6.8 Hz), 0.88 (3H, t, J = 7.0 Hz). 13 12 (1H, m), 3.21 (1H, dd, J = 13.6, 11 14 (11H, m) , 0.81 (3H, t, J = 6.9 Hz). 13 
(R)-4-Benzyl-3-[(2S,3S,E)-3-hydroxy-2-methyldec-4-enoyl]oxazolidin-2-one (14)
N
Synthesis of S-and R-E-2-methyldec-3-enoyl-CoA esters (3S) and (3R)

Synthesis of S-and R-E-2-methyldec-3-enoyl-
(R)-4-Benzyl-3-[(R)-2-methylbut-3-enoyl]oxazolidin-2-one (21R) and (R)-4-benzyl-3-[(S)-2-
methylbut-3-enoyl]oxazolidin-2-one (21S)
(2S,E)-2-Methyldec-3-enoyl-CoA (3S)
S-CoA O Compound 3S was prepared from 7S (15 mg), following the same procedure as for compound 2R to
Synthesis of E-2-methyldec-2-enoyl-CoA (4)
Ylide 23 was prepared using the method of Baktharaman et al. 22 and the desired unsaturated ester 24 prepared by Wittig reaction between ylide 23 and octanal. Ester 24 was hydrolysed to the acid 9 under basic conditions, which was converted to 4 by the literature procedure. 
AMACR assays 1,2
Human AMACR was expressed in E. coli Rosetta2 (DE3) at 22 °C overnight shaking at 220 r.p.m., inducting with 0.25 mM IPTG. Cells (~2 g) were lysed using the 'one shot' in ~30 mL 20 mM NaH 2 PO 4 -NaOH, 300 mM NaCl, 10 mM imidazole, pH 7.2 supplemented with 1 mM PMSF and 250 u benzonase (Novagen) and stirred with N-lauroyl-sarcosine at 4 °C for 1 hour. Following centrifugation, enzyme was purified by metal-chelate chromatography, dialysed into 10 mM NaH 2 PO 4 -NaOH, pH 7.4 and stored at -80 °C. Protein purity of pooled fractions was ca. 95 -98 % by SDS-PAGE analyses. Protein concentrations were quantified using UV-visible absorbance 2 at 280 nm (ε 280 = 35785 M -1 cm -1 ) and assumed a molecular mass of 47146.8 Da. for the His-tag protein. 1 Assays were conducted in 50 mM NaH 2 PO 4 -NaOH, pH 7.4 containing ca. 85% 2 H 2 O and 100 µM acyl-CoA substrate as previously described, with negative controls contain heat-inactivated enzyme.
±-Fenoprofenoyl-CoA or S-2-methyldecanoyl-CoA with wild-type enzyme were used as positive controls. 1,2 Assays were quenched by heating to 50 °C for 10 minutes before 1 H NMR analysis (500.13 MHz). Conversion of substrates was quantified by conversion of the 2-Me doublet at ca. Unsaturated 2-methylacyl-CoA esters 3R and 3S as substrates for AMACR F Figure S1 . 3R shows exchange of the α-proton in with live AMACR in 2 H 2 O. This results in the doublet of the methyl group at 1.04 ppm becoming a singlet (outlined in green) and the concomitant conversion of the doublet of doublets for H a at 5.29 ppm into a doublet (outlined in red). As exchange is an obligatory step in chiral inversion, it is highly likely that racemization also occurs.
An identical reaction occurred upon incubation of 3S with AMACR under identical conditions (data not shown). 
